Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
FMCG firm Jyothy Labs Ltd has posted a 77.25 per cent jump in its consolidated net profit at Rs 67.39 crore in the third quarter ended December 31, 2022. The company had posted a consolidated net profit of Rs 38.02 crore in the same period last fiscal, it said in a regulatory filing. Consolidated revenue from operations was at Rs 612.67 crore during the quarter under review as compared to Rs 539.03 crore in the year-ago period, it added. "The business has been resilient in spite of high commodity inflation impacting the consumption across categories. We have been focussed only on execution to drive higher operating revenues and manage margins in the inflationary environment," it said. The company said it has focussed on a strategy to build scale and gain market share backed by enhanced distribution, including reaching out to newer geographies, increase brand visibility and product innovation initiatives. "We continue to drive execution-led growth to build scale. This will deliver
FMCG firm Jyothy Labs Ltd on Wednesday reported a 77.25 per cent jump in its consolidated net profit at Rs 673.9 crore in the third quarter ended December 31, 2022. The company had posted a consolidated net profit of Rs 380.2 crore in the same period last fiscal, it said in a regulatory filing. Consolidated revenue from operations were at Rs 6,126.7 crore during the quarter under review as compared to Rs 5,390.3 crore in the year-ago period, it added. "The business has been resilient in spite of high commodity inflation impacting the consumption across categories. We have been focussed only on execution to drive higher operating revenues and manage margins in the inflationary environment," it said. The company said it has focussed on a strategy to build scale and gain market share backed by enhanced distribution, including reaching out to newer geographies, increase brand visibility and product innovation initiatives. "We continue to drive execution-led growth to build scale. This
Weak show of the household insecticides business (under thebrand name Maxo), which forms about a fourth of Jyothy Laboratories' (JyothyLabs') revenue, pulled down overall growth in the March quarter (Q4).Consequently, the company's consolidated revenue grew 4.2 per cent year-on-year(y-o-y) to ~446 crore, missing the Bloomberg consensus estimate of ~478 crore. While peer Godrej Consumer Products (GCPL), too, witnessedsome pressure on its household insecticides revenues in Q4, this business grewfour per cent; but for Jyothy Labs, the household insecticides' revenues fellsix per cent y-o-y in Q4, indicating it could have lost market share, unlikeGCPL which maintained its leadership position. While the company believeshousehold insecticides could improve in case of a normal monsoon, the Streetwill keep a close watch on it given the competitive intensity and its highcontribution to Jyothy Labs' top line.Other than the flattish growth in the smaller segment oflaundry services, Jyothy Labs'